Position in GH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$48,339,666
+$47,600,706 QoQ
Shares Held
322,200
+3927.5% QoQ
Ownership
0.240%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#73
of 596 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026FARALLON CAPITAL MANAGEMENT LLC holds $1,489,863,806 across 6 Diagnostics & Research names. GH ranks #4 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTRA |
Natera, Inc.
|
2,218,366 | $602,175,450 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
1,049,185 | $526,019,391 | |
| 3 | GRAL |
GRAIL, Inc.
|
4,161,584 | $284,111,339 | |
| 4 | GH |
Guardant Health, Inc.
This page
|
322,200 | $48,339,666 | |
| 5 | FRNM |
Freenome, Inc.
|
2,250,000 | $24,480,000 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
9,000 | $4,737,960 |
All Filings in GH
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $48,339,666 | 322,200 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $738,960 | 8,000 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $11,133,260 | 109,000 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $499,840 | 8,000 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $416,320 | 8,000 | Shares | Other | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||